Contact this trialFirst, we need to learn more about you.
Artificial Intelligence
AI Screening for Diabetic Retinopathy
Recruiting1 award
Montréal, Quebec
"This trial will test if an artificial intelligence algorithm called NeoRetina, created by DIAGNOS Inc., can accurately detect and grade the severity of diabetic retinopathy by analyzing eye fundus photographs."
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service